132 related articles for article (PubMed ID: 29077116)
1. Structural investigation of cyclo-dioxo maleimide cross-linkers for acid and serum stability.
Tobaldi E; Dovgan I; Mosser M; Becht JM; Wagner A
Org Biomol Chem; 2017 Nov; 15(44):9305-9310. PubMed ID: 29077116
[TBL] [Abstract][Full Text] [Related]
2. Long-term stabilization of maleimide-thiol conjugates.
Fontaine SD; Reid R; Robinson L; Ashley GW; Santi DV
Bioconjug Chem; 2015 Jan; 26(1):145-52. PubMed ID: 25494821
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of cysteine-linked antibody drug conjugates with N-aryl maleimides.
Christie RJ; Fleming R; Bezabeh B; Woods R; Mao S; Harper J; Joseph A; Wang Q; Xu ZQ; Wu H; Gao C; Dimasi N
J Control Release; 2015 Dec; 220(Pt B):660-70. PubMed ID: 26387744
[TBL] [Abstract][Full Text] [Related]
4. 2-(Maleimidomethyl)-1,3-Dioxanes (MD): a Serum-Stable Self-hydrolysable Hydrophilic Alternative to Classical Maleimide Conjugation.
Dovgan I; Kolodych S; Koniev O; Wagner A
Sci Rep; 2016 Aug; 6():30835. PubMed ID: 27501860
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Ring-Opening Reaction of Succinimide Linkers in ADCs.
Zheng K; Chen Y; Wang J; Zheng L; Hutchinson M; Persson J; Ji J
J Pharm Sci; 2019 Jan; 108(1):133-141. PubMed ID: 30458165
[TBL] [Abstract][Full Text] [Related]
6. Improving the stability of thiol-maleimide bioconjugates via the formation of a thiazine structure.
Gober IN; Sharan R; Villain M
J Pept Sci; 2023 Oct; 29(10):e3495. PubMed ID: 37055943
[TBL] [Abstract][Full Text] [Related]
7. Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates.
Shen BQ; Xu K; Liu L; Raab H; Bhakta S; Kenrick M; Parsons-Reponte KL; Tien J; Yu SF; Mai E; Li D; Tibbitts J; Baudys J; Saad OM; Scales SJ; McDonald PJ; Hass PE; Eigenbrot C; Nguyen T; Solis WA; Fuji RN; Flagella KM; Patel D; Spencer SD; Khawli LA; Ebens A; Wong WL; Vandlen R; Kaur S; Sliwkowski MX; Scheller RH; Polakis P; Junutula JR
Nat Biotechnol; 2012 Jan; 30(2):184-9. PubMed ID: 22267010
[TBL] [Abstract][Full Text] [Related]
8. Tuning the Hydrolytic Stability of Next Generation Maleimide Cross-Linkers Enables Access to Albumin-Antibody Fragment Conjugates and tri-scFvs.
Forte N; Livanos M; Miranda E; Morais M; Yang X; Rajkumar VS; Chester KA; Chudasama V; Baker JR
Bioconjug Chem; 2018 Feb; 29(2):486-492. PubMed ID: 29384367
[TBL] [Abstract][Full Text] [Related]
9. Manipulation of Glutathione-Mediated Degradation of Thiol-Maleimide Conjugates.
Wu H; LeValley PJ; Luo T; Kloxin AM; Kiick KL
Bioconjug Chem; 2018 Nov; 29(11):3595-3605. PubMed ID: 30285419
[TBL] [Abstract][Full Text] [Related]
10. Comparison of hydrazone heterobifunctional cross-linking agents for reversible conjugation of thiol-containing chemistry.
Christie RJ; Anderson DJ; Grainger DW
Bioconjug Chem; 2010 Oct; 21(10):1779-87. PubMed ID: 20695431
[TBL] [Abstract][Full Text] [Related]
11. Maleimidocysteineamido-DOTA derivatives: new reagents for radiometal chelate conjugation to antibody sulfhydryl groups undergo pH-dependent cleavage reactions.
Lewis MR; Shively JE
Bioconjug Chem; 1998; 9(1):72-86. PubMed ID: 9460549
[TBL] [Abstract][Full Text] [Related]
12. Optimised approach to albumin-drug conjugates using monobromomaleimide-C-2 linkers.
Wall A; Nicholls K; Caspersen MB; Skrivergaard S; Howard KA; Karu K; Chudasama V; Baker JR
Org Biomol Chem; 2019 Aug; 17(34):7870-7873. PubMed ID: 31410415
[TBL] [Abstract][Full Text] [Related]
13. Where Did the Linker-Payload Go? A Quantitative Investigation on the Destination of the Released Linker-Payload from an Antibody-Drug Conjugate with a Maleimide Linker in Plasma.
Wei C; Zhang G; Clark T; Barletta F; Tumey LN; Rago B; Hansel S; Han X
Anal Chem; 2016 May; 88(9):4979-86. PubMed ID: 27075639
[TBL] [Abstract][Full Text] [Related]
14. Tuning the Diels-Alder Reaction for Bioconjugation to Maleimide Drug-Linkers.
St Amant AH; Lemen D; Florinas S; Mao S; Fazenbaker C; Zhong H; Wu H; Gao C; Christie RJ; Read de Alaniz J
Bioconjug Chem; 2018 Jul; 29(7):2406-2414. PubMed ID: 29932647
[TBL] [Abstract][Full Text] [Related]
15. Single Mutation on Trastuzumab Modulates the Stability of Antibody-Drug Conjugates Built Using Acetal-Based Linkers and Thiol-Maleimide Chemistry.
Ferhati X; Jiménez-Moreno E; Hoyt EA; Salluce G; Cabeza-Cabrerizo M; Navo CD; Compañón I; Akkapeddi P; Matos MJ; Salaverri N; Garrido P; Martínez A; Laserna V; Murray TV; Jiménez-Osés G; Ravn P; Bernardes GJL; Corzana F
J Am Chem Soc; 2022 Mar; 144(12):5284-5294. PubMed ID: 35293206
[TBL] [Abstract][Full Text] [Related]
16. Improving the Stability of Maleimide-Thiol Conjugation for Drug Targeting.
Lahnsteiner M; Kastner A; Mayr J; Roller A; Keppler BK; Kowol CR
Chemistry; 2020 Dec; 26(68):15867-15870. PubMed ID: 32871016
[TBL] [Abstract][Full Text] [Related]
17. N-(1-pyrene)maleimide: a fluorescent cross-linking reagent.
Wu CW; Yarbrough LR
Biochemistry; 1976 Jun; 15(13):2863-8. PubMed ID: 7290
[TBL] [Abstract][Full Text] [Related]
18. Maleimide-dimethylfuran exo adducts: effective maleimide protection in the synthesis of oligonucleotide conjugates.
Sánchez A; Pedroso E; Grandas A
Org Lett; 2011 Aug; 13(16):4364-7. PubMed ID: 21790151
[TBL] [Abstract][Full Text] [Related]
19. Understanding How the Stability of the Thiol-Maleimide Linkage Impacts the Pharmacokinetics of Lysine-Linked Antibody-Maytansinoid Conjugates.
Ponte JF; Sun X; Yoder NC; Fishkin N; Laleau R; Coccia J; Lanieri L; Bogalhas M; Wang L; Wilhelm S; Widdison W; Pinkas J; Keating TA; Chari R; Erickson HK; Lambert JM
Bioconjug Chem; 2016 Jul; 27(7):1588-98. PubMed ID: 27174129
[TBL] [Abstract][Full Text] [Related]
20. Radiosynthesis of new [90Y]-DOTA-based maleimide reagents suitable for the prelabeling of thiol-bearing L-oligonucleotides and peptides.
Schlesinger J; Fischer C; Koezle I; Vonhoff S; Klussmann S; Bergmann R; Pietzsch HJ; Steinbach J
Bioconjug Chem; 2009 Jul; 20(7):1340-8. PubMed ID: 19552458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
